Nuzhat Ahmed 36th Lorne Cancer Conference 2024

Abstracts this author is presenting:

• Eribulin reduces sunitinib resistance by reversing hypoxia and epithelial mesenchymal transition associated metabolic reprograming in preclinical human clear cell renal carcinoma model. — Welcome Function & Poster Session I